Knocking Out One Amino Acid Phosphorylation Site Cut Mouse Exercise Capacity by Two-Thirds

Every time you exercise hard, an enzyme called AMPK activates inside your muscle cells. It senses the sudden spike in energy demand, then triggers a cascade of responses - increasing the number and activity of mitochondria, the power-generating organelles in the cell, and mobilizing sugar reserves for immediate fuel. AMPK has been studied for decades. But precisely which molecular events initiate and propagate its signaling has remained incompletely mapped. A study published in Science Advances from Virginia Tech's Fralin Biomedical Research Institute fills in a specific gap, and the result pointed the researchers toward an unexpected connection to diabetes.

One Site, Broad Effects

The study focused on a phosphorylation site on the AMPK protein - a location where a phosphate group is added by an upstream signaling molecule, changing AMPK's activity. The team, led by Zhen Yan, professor at the Fralin Biomedical Research Institute and director of its Center for Exercise Medicine Research, used gene editing to disable this site without disrupting the broader AMPK protein structure or its associated partner proteins. This approach isolated the site's specific contribution to AMPK function.

The result was dramatic. Mice with this single signaling site disabled showed a dramatically reduced ability to exercise: they ran approximately one-third the distance covered by typical mice under the same testing conditions. The enzyme could not properly respond to the demand for energy in working muscle cells, confirming that the site is essential to the signaling process.

"The data suggest that AMPK is not only important for maintaining the quantity of mitochondria but also regulating other processes leading to mitochondrial metabolism and regulation of protein function for muscle contraction," said Yan.

More Than Mitochondria

Previous work had established AMPK's role in regulating mitochondrial quantity - the cellular mechanism by which exercise training builds endurance over time. The new data confirmed that role but also revealed that the same phosphorylation site regulates a broader set of functions than previously recognized: muscle contraction signaling and glucose metabolism, specifically the breaking down of sugar for energy.

These additional regulatory functions were not anticipated at the outset of the study. They suggest that AMPK, through this single signaling site, integrates multiple aspects of the cellular response to energy stress - not just the long-term adaptation (building more mitochondria) but also the immediate responses required during exercise itself.

The Diabetes Connection

First author Ryan Montalvo, a postdoctoral associate in the Yan Lab, extended the analysis by comparing protein patterns in the skeletal muscle of the experimental mice with published data from human diabetic patients. The overlap was significant: the molecular signature of impaired AMPK signaling in the mice resembled what had been observed in patients with diabetes.

This correlation does not establish causation. Observing that protein patterns in mice with disabled AMPK match those in diabetic humans is suggestive but cannot, on its own, confirm that AMPK dysfunction contributes to diabetes in patients or that restoring AMPK activity would improve metabolic health. But it is a specific enough pattern to warrant investigation.

"That suggests that if we target AMPK with drug interventions, we may be able to help diabetic patients," Yan said. The team's immediate next step is examining AMPK's role in exercise adaptation - how muscle remodels in response to training - to understand whether the same phosphorylation site governs the longer-term changes that make regular exercise beneficial for metabolic health.

The study was conducted entirely in mice. Whether the same phosphorylation site plays equivalent roles in human muscle physiology, and whether pharmacological targeting of this site in humans would produce beneficial effects without unwanted consequences, are open questions requiring separate investigation. The study published February 25, 2026, in Science Advances.